Buttyan R - Search Results

1

Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.

de la Taille A, Katz A, Cao Y, McKiernan J, Buttyan R, Burchardt M, Burchardt T, Hayek O, Olsson CA, Chopin DK, Sawczuk IS. de la Taille A, et al. Among authors: buttyan r. Urology. 2000 Sep 1;56(3):393-8. doi: 10.1016/s0090-4295(00)00647-6. Urology. 2000. PMID: 10962301

2

Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors.

Gilbert SM, Whitson JM, Mansukhani M, Buttyan R, Benson MC, Olsson CA, Sawczuk IS, McKiernan JM. Gilbert SM, et al. Among authors: buttyan r. Urology. 2006 May;67(5):942-5. doi: 10.1016/j.urology.2005.11.034. Urology. 2006. PMID: 16698354

3

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, Katz AE. Olsson CA, et al. Among authors: buttyan re. J Urol. 1996 May;155(5):1557-62. J Urol. 1996. PMID: 8627821 Free article.

4

Renal growth factor expression during the early phase of experimental hydronephrosis.

Walton G, Buttyan R, Garcia-Montes E, Olsson CA, Hensle TW, Sawczuk IS. Walton G, et al. Among authors: buttyan r. J Urol. 1992 Aug;148(2 Pt 2):510-4. doi: 10.1016/s0022-5347(17)36641-7. J Urol. 1992. PMID: 1640512 Free article.

5

Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury.

Bandyk MG, Sawczuk IS, Olsson CA, Katz AE, Buttyan R. Bandyk MG, et al. Among authors: buttyan r. J Urol. 1990 Feb;143(2):407-13. doi: 10.1016/s0022-5347(17)39975-5. J Urol. 1990. PMID: 2299741 Free article.

6

Gene expression in renal growth and regrowth.

Sawczuk IS, Olsson CA, Buttyan R, Nguyen-Huu MC, Zimmerman KA, Alt FW, Zakeri Z, Wolgemuth D, Reitelman C. Sawczuk IS, et al. Among authors: buttyan r. J Urol. 1988 Nov;140(5 Pt 2):1145-8. doi: 10.1016/s0022-5347(17)41983-5. J Urol. 1988. PMID: 3054158

7

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R. Katz AE, et al. Among authors: buttyan r. Urology. 1994 Jun;43(6):765-75. doi: 10.1016/0090-4295(94)90132-5. Urology. 1994. PMID: 7515202

8

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.

Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, McMahon D, Benson MC, Katz AE. Cama C, et al. Among authors: buttyan r. J Urol. 1995 May;153(5):1373-8. J Urol. 1995. PMID: 7536252 Free article.

9

Molecular staging of genitourinary malignancies.

Katz AE, De Vries GM, Olsson CA, Benson MC, Swanton P, Ikeguchi EF, Buttyan R. Katz AE, et al. Among authors: buttyan r. Urology. 1996 Jun;47(6):948-58. doi: 10.1016/S0090-4295(96)00110-0. Urology. 1996. PMID: 8677601 Free article. Review. No abstract available.

10

The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer.

Olsson CA, De Vries GM, Benson MC, Raffo A, Buttyan R, Cama C, O'Toole K, Katz AE. Olsson CA, et al. Among authors: buttyan r. Br J Urol. 1996 Mar;77(3):411-7. doi: 10.1046/j.1464-410x.1996.90616.x. Br J Urol. 1996. PMID: 8814848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters